Autobio(SH:603658) 2 1 Shi Ji Jing Ji Bao Dao·2025-12-09 09:31Core Viewpoint - Antu Biology announced the approval of a proposal to utilize idle raised funds for cash management to enhance fund efficiency [1] Group 1: Fund Management - The company plans to use up to 140 million yuan of idle funds from convertible bonds and up to 1.54 billion yuan from non-publicly issued stock for investments in safe and liquid principal-protected products [1] - The investment options include structured deposits, large certificates of deposit, reverse repos of government bonds, broker income certificates, and broker wealth management products [1] - The approved cash management plan is valid for 12 months from the date of the board's approval, allowing for rolling use of funds within the specified limits [1] Group 2: Impact on Operations - The company clarified that this cash management initiative will not affect the progress of investment projects funded by the raised capital or the normal production and operation of the company [1]